How to use Technologies offered

A search for a cancer, preclinical stage, synthetic opportunity would use the selection "Therapeutics, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform Technology' in 'Sector' will identify all kinds of research technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each technology profile gives the name of a company or academic institute as source of the offer, and a link allowing to contact the potential licensor. In most cases a profile includes a pdf covering the available non-confidential information as well as detailed contact data.

Registered users can create non-public notifications profiles which will inform them about new 'Technologies Offered' entries fitting their needs as specified. In addition these profiles allow them to filter the available information more comfortably.

Name

Gfi11b/1b-mouse model

Organization name

PROvendis GmbH

Profile

Background

Gfi1 is a transcriptional repressor being expressed in the hematopoietic and nervous system. Loss of function leads to severe defects in hematopoiesis and inner ear development. Gfi1 is highly similar to its paralogue Gfi1b with almost identical sequences in their respective protein domains.Ut

Technology

A knock-in mouse model was created in which the Gfi1 coding region was replaced by Gfi1b.

The Gfi11b/1b-mice did not exhibit significant defects in the hematopoietic system as previously described for Gfi1-/--mice, suggesting that Gfi1b is able to rescue the loss of Gfi1-function.

Interestingly, however, the Gfi11b/1b-mice showed significant defects in inner ear development, i.e. hair cell formation, leading to hearing loss.

These results point to some interesting mechanisms on the molecular level for the differentiation and maintenance of hearing.

This makes the Gfi11b/1b-model a valuable tool for the development of novel approaches for treating hearing loss.

Current Status       

On behalf of the University of Duisburg-Essen, PROvendis offers access to the mouse model under a Material License Agreement.

A matching mouse model of a Gfi1 point mutation, Gfi1P2A/P2A is available with Ref. No. 3947.

Relevant Publication

Fiolka et al. (2006): Gfi1 and Gfi1b act equivalently in haematopoiesis, but have distinct, non-overlapping functions in inner ear development. EMBO Reports, 7(3): 326-333.

Möröy (2005): The zinc finger transcription factor Growth factor independence 1 (Gfi1). Int J Biochem Cell Biol. 37: 541-546.

Wallis et al. (2003): The zinc finger transcription factor Gfi1, implicated in lymphomagenesis, is required for inner ear hair cell differentiation and survival development. 130: 221-232.

Saleque et al. (2002): The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev. 16: 301-306.

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.

 
 

latest entries